TRIPLE NEGATIVE

Clinical trials for TRIPLE NEGATIVE explained in plain language.

Never miss a new study

Get alerted when new TRIPLE NEGATIVE trials appear

Sign up with your email to follow new studies for TRIPLE NEGATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo aims to wipe out hidden breast cancer cells after standard treatment

Disease control Recruiting now

This study tests whether adding the drug sarilumab to chemotherapy (capecitabine) can eliminate tiny amounts of cancer left behind after standard treatment in people with triple negative breast cancer, a very aggressive type. The goal is to prevent the cancer from coming back and…

Matched conditions: TRIPLE NEGATIVE

Phase: PHASE1, PHASE2 • Sponsor: University of Southern California • Aim: Disease control

Last updated Jun 15, 2026 19:02 UTC

TRIPLE NEGATIVE

Get alerted when new TRIPLE NEGATIVE trials appear

New combo aims to wipe out hidden breast cancer cells after standard treatment